Aclerastide (DSC-127; NorLeu-3-A(1-7)) is an angiotensin analogue that is being developed by Derma Sciences (a subsidiary of Integra LifeSciences) for the treatment for wounds such as diabetic foot ulcer and surgical scars. The mechanisms of action include induction of progenitor proliferation, accelerated vascularization, collagen deposition, and re-epithelialization. Aclerastide recently failed in phase III clinical trials for treatment of diabetic foot ulcers. Phase I development of aclerastide ophthalmic solution is ongoing in the US.
Originator
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT01849965
Aclerastide 0.03%, daily topical application to diabetic foot ulcer for a period of up to 28 days
Route of Administration:
Topical
Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 16:41:07 UTC 2023
by
admin
on
Sat Dec 16 16:41:07 UTC 2023
|
Protein Sub Type | |
Sequence Type | COMPLETE |
Record UNII |
YYD6UT8T47
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
414813
Created by
admin on Sat Dec 16 16:41:07 UTC 2023 , Edited by admin on Sat Dec 16 16:41:07 UTC 2023
|
||
|
FDA ORPHAN DRUG |
414713
Created by
admin on Sat Dec 16 16:41:07 UTC 2023 , Edited by admin on Sat Dec 16 16:41:07 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
9811551
Created by
admin on Sat Dec 16 16:41:07 UTC 2023 , Edited by admin on Sat Dec 16 16:41:07 UTC 2023
|
PRIMARY | |||
|
DB12631
Created by
admin on Sat Dec 16 16:41:07 UTC 2023 , Edited by admin on Sat Dec 16 16:41:07 UTC 2023
|
PRIMARY | |||
|
C169759
Created by
admin on Sat Dec 16 16:41:07 UTC 2023 , Edited by admin on Sat Dec 16 16:41:07 UTC 2023
|
PRIMARY | |||
|
9877
Created by
admin on Sat Dec 16 16:41:07 UTC 2023 , Edited by admin on Sat Dec 16 16:41:07 UTC 2023
|
PRIMARY | |||
|
YYD6UT8T47
Created by
admin on Sat Dec 16 16:41:07 UTC 2023 , Edited by admin on Sat Dec 16 16:41:07 UTC 2023
|
PRIMARY | |||
|
227803-63-6
Created by
admin on Sat Dec 16 16:41:07 UTC 2023 , Edited by admin on Sat Dec 16 16:41:07 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|
||||
Molecular Formula | CHEMICAL |
|